1. Introduction {#sec1-ijms-18-02215}
===============

Bioorganometallic compounds are reputed for their remarkable applications in the field of catalysis; however, much less is known about their potential in chemical biology \[[@B1-ijms-18-02215],[@B2-ijms-18-02215]\]. An important goal in organometallic chemistry is the synthesis of biomolecules that exhibit catalytic activity analogous to the activity of enzymes. A number of catalysts having biomimetic activity for different enzymes have been designed by chemists \[[@B3-ijms-18-02215],[@B4-ijms-18-02215]\]. The preparation and etude of efficient template complexes for metalloenzymes with oxidase or oxygenase activity are thus most important for the elaboration of new veritable catalysts for oxidation reactions \[[@B5-ijms-18-02215]\]. Copper ions, as centers of potent site of various metalloproteins, play an essential role in several biological processes: electron transfer, oxidation, transport of dioxygen, etc. \[[@B6-ijms-18-02215],[@B7-ijms-18-02215]\]. Copper complexes of low molecular weight are studied as structural and functional models of active centers of enzymes with copper \[[@B8-ijms-18-02215],[@B9-ijms-18-02215],[@B10-ijms-18-02215],[@B11-ijms-18-02215]\].

Catechol oxidases perform the oxidation of 1,2-diphenols, such as catechol, to *o*-quinones, using dioxygen (O~2~). Hydrogen atoms removed from catechol combine with oxygen to form water. The crystal structures of different forms of catechol oxidase have improved the accordance of the mechanism of catecholase activity of catechol oxidase. Several workers proposed the mechanism of catechol oxidation by natural enzyme, including important proposals by Solomon and kerbs \[[@B12-ijms-18-02215],[@B13-ijms-18-02215]\]. In addition to the high number of Cu(II) complexes reported, their catecholase activity has also been demonstrated, although their mechanistic aspects are not as well understood as those of Cu(II) complexes \[[@B14-ijms-18-02215],[@B15-ijms-18-02215],[@B16-ijms-18-02215],[@B17-ijms-18-02215],[@B18-ijms-18-02215]\].

Hydrazones are members of the Schiff bases family, which are built with aromatic acid hydrazides and carbonyl compounds. They are quite interesting in coordination chemistry as they present a combination of donor sites, such as a protonated/deprotonated amide oxygen atom, imine nitrogen atom of the hydrazone moiety and an additional donor site (usually *N* or *O*) provided from the aldehyde or ketone \[[@B19-ijms-18-02215],[@B20-ijms-18-02215]\]. Hydrazones form wide variety of complexes with chemical, structural, biological and industrial importance \[[@B21-ijms-18-02215],[@B22-ijms-18-02215],[@B23-ijms-18-02215]\]. These proprieties are attributed to the formation of stable chelate complexes with transition metals which catalyze physiological processes \[[@B24-ijms-18-02215],[@B25-ijms-18-02215]\].

In this study, we report the synthesis of six new hydrazone derivatives containing pyrazole moiety with a good yield ([Scheme 1](#ijms-18-02215-sch001){ref-type="scheme"}). The X-ray crystal structures of compounds **L1** and **L2** were determined, and their geometrical parameters were compared with theoretical DFT calculations at the B3LYP level of theory. The investigation of catalytic activities of copper (II)-ligand complexes towards oxidation of catechol to *o*-quinone was studied. All of the parameters that can affect the catalytic efficiency were studied.

2. Results {#sec2-ijms-18-02215}
==========

2.1. Synthesis {#sec2dot1-ijms-18-02215}
--------------

Synthesis of hydrazones (**L1**--**L6**) is outlined in [Scheme 1](#ijms-18-02215-sch001){ref-type="scheme"}. Starting compound, ethyl 3-phenyl-*1H*-pyrazole-5-carboxylate (**1**), was readily synthesized by the reaction of ethyl-2,4-dioxo-4-phenyl-butanoate, obtained from acetophenone, and diethyl oxalate, with hydrazine in the presence of sulfuric acid at room temperature. The reaction of ethyl 3-phenyl-*1H*-pyrazole-5-carboxylate (**1**) with hydrazine hydrate in ethanol afforded 3-phenyl-1*H*-pyrazole-5-carbohydrazide (**2**). Finally, the novel desired hydrazones (**L1**--**L6**) were obtained by condensing compound (**2**) with aromatic aldehydes at reflux of ethanol using acetic acid as reported in our previous procedure \[[@B26-ijms-18-02215],[@B27-ijms-18-02215],[@B28-ijms-18-02215]\]. The expected products were isolated as crystalline materials with reliable to excellent yields.

2.2. X-Ray Crystal Structures Description {#sec2dot2-ijms-18-02215}
-----------------------------------------

Compounds **L1** and **L2** were analyzed by X-ray diffraction. Refinement parameters and crystal data are listed in [Table S1](#app1-ijms-18-02215){ref-type="app"}. [Supplementary data](#app1-ijms-18-02215){ref-type="app"} are deposited with the Cambridge Crystallographic Data Centre (CCDC) under deposition numbers 1522882 and 1523265.

The selected bond lengths and bond angles and hydrogen bonds are listed in [Tables S2--S5 in the Supplementary Materials](#app1-ijms-18-02215){ref-type="app"}. The asymmetric unit of **L1** contains one independent molecule with DMF and water molecules as mixed crystallizing solvent, as shown in [Figure 1](#ijms-18-02215-f001){ref-type="fig"}. All the bind lengths and angles are in normal ranges. In the crystal wrap, molecules are connected via many classical and non-classical intermolecular hydrogen bonds ([Table S3](#app1-ijms-18-02215){ref-type="app"}). [Figure 2](#ijms-18-02215-f002){ref-type="fig"} shows the crystal structure of **L2**. In the crystal structure, the pyrazole ring (N1/N2/C7--C9) makes dihedral angles with the phenyl ring (C1--C6) and tolyl ring (C12--C17), at 23.39° and 36.16°, respectively. In the crystal wrap, molecules are linked via two classical intermolecular hydrogen bonds between N1---H1N1···O1i and N3---H1N3···N2ii, Symmetry codes: (i) *x*, −*y*+1, *z*+1/2; and (ii) −*x*+1, *y*, −*z*+3/2 ([Table S5](#app1-ijms-18-02215){ref-type="app"}).

2.3. Computational Studies {#sec2dot3-ijms-18-02215}
--------------------------

Comparison of the theoretical values with the experimental ones indicates that all the optimized bond lengths are closer to the experimental values. In the case of X-ray structure of compound **L1**, the observed bond lengths of C1--C10, O3--C15 and N3--N4 bonds in five-membered pyrazole ring are 1.227(3) Å, 1.363(3) Å and 1.383(3) Å, respectively. The calculated bond lengths, through DFT method, of same pyrazole ring are 1.24394 Å, 1.38125 Å and 1.37144 Å, respectively, which are very close to the actual values. In [Table 1](#ijms-18-02215-t001){ref-type="table"}, it is clear that actual C-C and C-H bond lengths are also in close agreement with calculated values. The calculated bond angles for O1--C10--C9, C14--O2--C18 and N4--C11--C12 bond angles of **L1** are 122.22°, 118.52°, 121.37°, respectively, which are close to the corresponding actual angles obtained from X-ray. The actual values of above bond angles are 121.3°, 118.3°, and 122.9°, respectively.

The optimized geometry of compounds **L1** and **L2** were obtained at B3LYP/6-31G\* level. Some optimized geometric parameters are also listed in [Figure 3](#ijms-18-02215-f003){ref-type="fig"}, and [Table 2](#ijms-18-02215-t002){ref-type="table"} and [Table 3](#ijms-18-02215-t003){ref-type="table"}.

The total energy, energy of HOMO and energy of LUMO, as well as other parameters for structures **L1** and **L2** are obtained theoretically and listed in [Table 3](#ijms-18-02215-t003){ref-type="table"}. The HOMO and LUMO electron density distributions of **L1** and **L2** are given in [Figure 4](#ijms-18-02215-f004){ref-type="fig"} and [Figure 5](#ijms-18-02215-f005){ref-type="fig"}, respectively. After the analysis of the theoretical results obtained, we can say that molecules **L1** and **L2** have a non-planar structure. DFT calculation gives an idea about the substance reactivity and site selectivity of the frameworks. EHOMO; ELUMO, which clarifies the inevitable charge exchange collaboration inside the studied material; electronegativity (χ); hardness (η); potential (μ); electrophilicity (ω); softness (S); and softness (*σ*) are recorded in [Table 3](#ijms-18-02215-t003){ref-type="table"}. The significance of η and ϭ is to evaluate both the reactivity and stability.

The analysis of the wave function indicates that the energy space between the molecular orbit HOMO and LUMO determines the chemical stability and the electrical transport properties of the molecule. The red and green colors of the molecular orbital ridge, respectively, represent the positive and negative phases.

The HOMO of **L1** shows the charge density localized on the 4-hydroxy-3-methoxybenzaldehyde ring, while LUMO is characterized by a charge distribution on the hydrazone function, indicating that this moiety can influence the electron transition. The HOMO of **L2** has a localized charge density on the pyrazole and hydrazone function, but LUMO is characterized by a charge distribution on the 4-methylbenzaldehyde ring and the hydrazone function. The energy difference between HOMO and LUMO of **L1** and **L2** is about 4.38 and 5.75 eV, respectively.

The energy of the smaller band space increases the stability of the molecule. The molecular boundary orbitals of **L1** and **L2** (HOMO--LUMO) are shown in [Figure 4](#ijms-18-02215-f004){ref-type="fig"} and [Figure 5](#ijms-18-02215-f005){ref-type="fig"}, respectively.

2.4. Catecholase Activity: Spectrophotometric Study {#sec2dot4-ijms-18-02215}
---------------------------------------------------

Catechol oxidation reaction catalyzed by copper complexes with ligands **L1**--**L6** is followed by the evolution of *o*-quinone absorbance measured at 390 nm with a UV-vis spectrometer ([Scheme 2](#ijms-18-02215-sch002){ref-type="scheme"}).

The catalytic oxidation rate variations from one complex to another are shown in [Figures S1--S5](#app1-ijms-18-02215){ref-type="app"}. On the other hand, catechol oxidation rates were calculated and collected in [Table 4](#ijms-18-02215-t004){ref-type="table"}. According to these results, we find that all copper complexes, formed in situ from ligands **L1**--**L6** and salts of copper, catalyze the oxidation reaction of catechol to *o*-quinone, but with different rates. The catalytic activities depend highly on the ligand concentration, the nature of solvent and the type of inorganic anion ([Figures S1--S5](#app1-ijms-18-02215){ref-type="app"}).

It appears plainly that catalytic activity varies from one complex to another. All of the copper complexes formed by the hydrazone derivatives catalyze the oxidation reaction of catechol to *o*-quinone. The best is the **L6** ligand with highest oxidation rate for all copper salts with maximum reaction rate equal to 72.92 µmol·L^--1^·min^--1^ for CuSO~4~ followed by **L3** with maximum rate of 37.89 µmol·L^--1^·min^--1^ for Cu(NO~3~)~2~. Lowest recorded oxidation rates, whose values are less than 10 µmol·L^--1^·min^--1^, correspond to complex **L2**-CuCl~2~, followed by **L5**-(CuNO~3~)~2~ and **L4**-CuSO~4~, and then **L5**-CuCl~2~. The **L1** ligand seems to have nearly the same activity for all copper salts determined at about 10 µmol·L^--1^·min^--1^.

Basically, for any ligand used except **L6**, Cu(CH~3~COO)~2~ gives highest activities and CuCl~2~ gives lowest activities ([Figure 6](#ijms-18-02215-f006){ref-type="fig"}). Concerning CH~3~COO^−^ and ligands **L3**, **L4** and **L6**, the values of absorbance increase at the beginning of the reaction and then remain constant after a certain time. This has been explained in previous studies by a precipitation of the complex that can take place during this decrease in absorbance.

### 2.4.1. Effect of Ligand Concentration on the Catecholase Activity {#sec2dot4dot1-ijms-18-02215}

The effect of ligand concentration on catecholase activity is studied by varying the ratio of equivalent ligand **L6**: metallic salt Cu(CH~3~COO)~2~. Three tests were carried out in ratios: 1:1, 2:1 and 1:2. The results obtained show that the test with the ratio **L6**: Cu(CH~3~COO)~2~ = 1:2 leads to higher oxidation rate value. Therefore, the **L6** complex that contains two cupric ion Cu(II) has a better catalytic activity. However, ratios 2:1 and 1:1 lead to lower oxidation rate value, and ratio 2:1 exhibits maximum at 35 min, and after slightly decreases, probably due to complex precipitation ([Figure 7](#ijms-18-02215-f007){ref-type="fig"}).

### 2.4.2. Solvent Effect {#sec2dot4dot2-ijms-18-02215}

The effect of three solvents (MeOH, CH~3~CN and DMF) on the oxidation reaction with the ligand **L6** and the Cu(CH~3~COO)~2~ salt is studied in similar thermodynamic conditions. The results of that study are presented by the rate values obtained for the oxidation reaction ([Figure 8](#ijms-18-02215-f008){ref-type="fig"}). Using a polar protic solvent such as methanol promotes oxidation reaction much better than the other two aprotic solvents, i.e., acetonitrile and DMF. Our results seem to be in perfect agreement with previous studies and show that solvatation of copper by the aprotic and polar solvents such as DMF and CH~3~CN decreases the catalytic activity of the metal cation in the oxidation reaction of catechol to *o*-quinone.

### 2.4.3. Comparison with Alternative Catalysts {#sec2dot4dot3-ijms-18-02215}

[Table 5](#ijms-18-02215-t005){ref-type="table"} shows the catalytic activity by other catalysts reported in the literature. It is clear that the hydrazone--pyrazole derivatives, in particular ligand **L6**, described in this work present further improvement and show better values and higher activity for the effective aerobic oxidation of the catechol into *o*-quinone.

The superior catalytic activity observed for ligand **L6** is probably due to the stability of corresponding copper complex (catalyst) favored by the organic conjugate π bonds of the three benzene ring contained in the ligand and by the intense coordination bonds of the Schiff base. To our knowledge, the catalytic activity observed for ligand **L6** (72.920 µmol·L^--1^·min^--1^) is the most important among the catalysts described in the literature.

3. Experimental {#sec3-ijms-18-02215}
===============

3.1. General Methods {#sec3dot1-ijms-18-02215}
--------------------

The chemical reagents used in synthesis were purchased from Merck, Darmstadt, Germany or Aldrich, St. Louis, MO, USA; were of the highest commercially available purity; and were used without previous purification. Melting points were measured using a Büchi B-545 digital capillary melting point apparatus (BUCHI Labortechnik AG, Flawil, CH, Switzerland) and used without correction. Reactions were checked with TLC silica gel 60 F254 (MACHEREY-NAGEL, Neumann-Neander, Drun, Germany). Spectra IR were recorded on a VERTEX 70 FT-IR spectrometer (Perkin-Elmer, Billerica, MA, USA) and frequencies are reported in cm^−1^. The spectra of ^1^H NMR and ^13^C NMR were recorded in solution in DMSO-*d*~6~ on a Bruker Avance 300 NMR spectrometer (Bruker, MA, USA). The chemical shifts are expressed in parts per million (ppm) by using tetramethylsilane (TMS) as internal reference and coupling constants (J) are given in Hz. Mass spectra were collected using a API 3200 LC/MS/MS system (AB MDS Sciex, Ontario, Canada) equipped with an ESI source. DRX data were collected on a Bruker APEX-II D8 Venture area diffractometer (Bruker, MA, USA) equipped with graphite monochromatic Mo Kα radiation, λ = 0.71073 Å at 293 (2) and 296 (2) K, respectively. The electronic spectra of the ligand and its metal complexes ere measured on a Lambda 35 ES UV/VIS spectrophotometer (Perkin Elmer, Waltham, MA, USA) in the range of 200--900 nm.

3.2. Synthesis {#sec3dot2-ijms-18-02215}
--------------

### 3.2.1. Synthesis of 3-phenyl-1*H*-pyrazole-4-carbohydrazides (2) {#sec3dot2dot1-ijms-18-02215}

To a stirred solution of 1 mmol of the 3-phenyl-1*H*-pyrazole-4-carboxylate (**1**) in ethanol (10 mL), 2 mL of 80% hydrazine monohydrate was added. The reaction mixture was maintained under reflux for 5 h, until TLC indicated the end of reaction. Afterwards, the reaction mixture was poured onto ice and the solid formed was collected by filtration, washed with cold water and recrystallized from ethanol. Yield: 66%; m.p: 207--209 °C; IR (ν(cm^−1^)) : 3296--3203 (NH, NH~2~), 1629 (C=O); ^1^H NMR: (300 MHz, DMSO-*d*~6~, δ(ppm)) : 4.45 (s, 2*H*, NH~2~), 7.05 (1*H*, s, CH-pyrazole), 7.17--7.60 (5*H*, m, Ar-H), 9.38 (s, 1*H*, NHCO), 13.61 (1*H*, s, NH-pyrazole); ESI-MS: *m*/*z* = 203.3 \[M+H\]^+^, 225.1 \[M+Na\]^+^. The FT-IR, ^1^H NMR and mass spectra of compound **2** are shown in [Figures S6--S8](#app1-ijms-18-02215){ref-type="app"}.

### 3.2.2. General Procedure for the Synthesis of Ligands (**L1**--**L6**) {#sec3dot2dot2-ijms-18-02215}

To a solution of 5-phenyl-*1H*-pyrazole-4-carbohydrazide (**2**) (1 mmol) in 10 mL of ethanol, an equimolar amount of the appropriate benzaldehyde derivative was added in the presence of acetic acid. The mixture was maintained under reflux for 2--5 h, until TLC indicated the end of reaction. Then, the reaction mixture was cooled to 25 °C, and the precipitate formed was filtered out washed with ethanol and recrystallized from ethanol. The FT-IR, (^1^H, ^13^C) NMR and mass spectra of Ligands (**L1**--**L6**) are shown in [Figures S9--S30](#app1-ijms-18-02215){ref-type="app"}.

### 3.2.3. *N*'-(4-hydroxy-3-methoxybenzylidene)-5-phenyl-1*H*-pyrazole-3-carbohydrazide (**L1**) {#sec3dot2dot3-ijms-18-02215}

Yield: 85%; m.p: 229--231 °C; IR (ν(cm^−1^)): 3276 (NH), 1681 (C=O), 1568 (C=N); ^1^H NMR: (300 MHz, DMSO-*d*~6~, δ(ppm)): 3.81 (3H, s, -OCH~3~), 6.83 (d, J = 8.1 Hz, 1*H*, H-Ar), 7.18 (1*H*, s, CH-pyrazole), 7.26--7.49 (5*H*, m, Ar-H), 7.54 (s, 1*H*, H-Ar), 7.82 (d, J = 8.1 Hz, 1*H*, H-Ar), 8.39 (1*H*, s, N=CH), 11.51 (s, 1*H*, OH), 11.72 (s, 1*H*, NHCO), 13.72 (1*H*, s, NH-pyrazole); ^13^C NMR: (300 MHz, DMSO-*d*~6~, δ (ppm)): 56.04 (OCH~3~), 103.85 (CH, C4-pyrazole), 115.91 (CH, C-Ar), 122.53 (CH, C-Ar), 125.53 (CH, C-Ar), 126.37 (CH, C-Ar), 128.28 (CH, C-Ar), 129.07 (CHC-Ar), 129.33 (C, C-Ar), 129.54 (C-Ar), 144.12 (CH, N=CH), 145.85 (C, C3-pyrazole), 147.36 (C, C5-pyrazole), 148.63 (C, C-OH), 156.48 (C, C-OCH~3~), 158.40 (C, C=O). ESI-MS: *m*/*z* = 337.0 \[M+H\]^+^, 359.0 \[M+Na\]^+^.

### 3.2.4. *N*'-(4-methylbenzylidene)-5-phenyl-1*H*-pyrazole-3-carbohydrazide (**L2**) {#sec3dot2dot4-ijms-18-02215}

Yield: 90%; m.p: 297--299 °C; IR (ν(cm^−1^)): 3205 (NH), 1680 (C=O),1561 (C=N); ^1^H NMR: (300 MHz, DMSO-*d*~6~, δ(ppm)): 2.32 (3*H*, s, CH~3~), 7.25 (1*H*, s, CH-pyrazole), 7.33--7.61 (5*H*, m, Ar-H), 7.59 (d, J = 7.8 Hz, 2*H*, H-Ar), 7.81 (d, J = 7.8 Hz, 1*H*, H-Ar), 8.45 (1*H*, s, N=CH), 11.65 (s, 1*H*, NHCO), 13.78 (1*H*, s, NH-pyrazole); ^13^C NMR: (300 MHz, DMSO-*d*~6~, δ (ppm)): 21.50 (OCH~3~), 103.85 (CH, C4-pyrazole), 125.80 (CH, C-Ar), 127.53 (CH, C-Ar), 127.90 (CH, C-Ar), 128.94 (CH, C-Ar), 129.49 (CH, C-Ar), 129.92 (C, C-Ar), 132.18 (C, C-Ar), 136.80 (C, C-CH~3~), 140.28 (C, C3-pyrazole), 146.18 (CH, N=CH), 148.28 (C, C5-pyrazole), 158.50 (C, C=O). ESI-MS: *m*/*z* = 304.9 \[M+H\]^+^, 326.9 \[M+Na\]^+^.

### 3.2.5. *N*'-(4-chlorobenzylidene)-5-phenyl-1*H*-pyrazole-3-carbohydrazide (**L3**) {#sec3dot2dot5-ijms-18-02215}

Yield: 89%; m.p: 301--303 °C; IR (ν(cm^−1^)): 3207 (NH), 1680 (C=O), 1605 (C=N); ^1^H NMR: (300 MHz, DMSO-*d*~6~, δ(ppm)): 7.11 (1*H*, s, CH-pyrazole), 7.33--7.60 (5*H*, m, Ar-H), 7.59 (d, J = 7.2 Hz, 2*H*, H-Ar), 7.81 (d, J = 7.2 Hz, 1*H*, H-Ar), 8.46 (1*H*, s, N=CH), 11.65 (s, 1*H*, NHCO), 13.79 (1*H*, s, NH-pyrazole); ^13^C NMR: (300 MHz, DMSO-*d*~6~, δ (ppm)): 103.82 (CH, C4-pyrazole), 125.82 (CH, C-Ar), 127.53 (CH, C-Ar), 127.90 (CH, C-Ar), 128.99 (CH, C-Ar), 129.49 (CH, C-Ar), 129.91 (C, C-Ar), 132.18 (C, C-Ar), 140.28 (C, C- CH~3~), 148.20 (C, C3-pyrazole), 156.88 (CH, N=CH), 158.62 (C, C5-pyrazole), 164.13 (C, C=O). ESI-MS: *m*/*z* = 325.1 \[M+H\]^+^, 347.3 \[M+Na\]^+^.

### 3.2.6. *N*'-(4-fluorobenzylidene)-5-phenyl-1*H*-pyrazole-3-carbohydrazide (**L4**) {#sec3dot2dot6-ijms-18-02215}

Yield: 98%; m.p: 294--296 °C; IR (ν(cm^−1^)) : 3320 (NH), 1672 (C=O), 1604 (C=N); ^1^H NMR: (300 MHz, DMSO-*d*~6~, δ(ppm)): 7.21 (1*H*, s, CH-pyrazole), 7.25--7.38 (5*H*, m, Ar-H), 7.42 (d, J = 7.8 Hz, 2*H*, H-Ar), 7.81 (d, J = 7.8 Hz, 1*H*, H-Ar), 8.50 (1*H*, s, N=CH), 11.72 (s, 1*H*, NHCO), 13.79 (1*H*, s, NH-pyrazole); ^13^C NMR: (300 MHz, DMSO-*d*~6~, δ (ppm)): 103.86 (CH, C4-pyrazole), 125.82 (CH, CH-Ar), 128.98 (CH, C-Ar), 129.49 (CH, CH-Ar), 129.64 (C, C-Ar), 129.74 (CH, CH-Ar), 130.10 (C, CH-Ar), 130.22 (C, C-Ar), 146.97 (C, C3-pyrazole), 150.50 (CH, N=CH), 156.68 (C, C5-pyrazole), 161.90 (C, C=O), 165.18 (C, C-F). ESI-MS: *m*/*z* = 309.3 \[M+H\]^+^.

### 3.2.7. 5-phenyl-*N*'-(1-phenylethylidene)-1*H*-pyrazole-3-carbohydrazide (**L5**) {#sec3dot2dot7-ijms-18-02215}

Yield: 85%; m.p: 251--253 °C; IR (ν(cm^−1^)) : 3320 (NH), 1667 (C=O),1589 (C=N); ^1^H NMR: (300 MHz, DMSO-*d*~6~, δ(ppm)): 2.36 (3*H*, s, CH~3~), 7.24 (1*H*, s, CH-pyrazole), 7.42--7.84 (10*H*, m, Ar-H), 10.37 (s, 1*H*, NHCO), 13.82 (1*H*, s, NH-pyrazole); ^13^C NMR: (300 MHz, DMSO-*d*~6~, δ (ppm)): 21.51 (OCH~3~), 103.60 (CH, C4-pyrazole), 125.73 (CH, C-Ar), 127.72 (CH, C-Ar), 128.70 (CH, C-Ar), 129.01 (CH, C-Ar), 129.18 (CH, C-Ar), 129.56 (CH, C-Ar), 130.34 (C, C-Ar), 132.07 (C, C-Ar), 137.21 (C, C3-pyrazole), 144.82 (CH, N=CH), 146.45 (C, C5-pyrazole), 157.23 (C, C=O). ESI-MS: *m*/*z* = 305.4 \[M+H\]^+^.

### 3.2.8. *N*'-(diphenylmethylene)-5-phenyl-1*H*-pyrazole-3-carbohydrazide (**L6**) {#sec3dot2dot8-ijms-18-02215}

Yield: 82%; m.p: 200--202 °C; IR (ν(cm^−1^)): 3360 (NH), 1664 (C=O), 1537 (C=N); ^1^H NMR: (300 MHz, DMSO-*d*~6~, δ(ppm)): 7.20 (1*H*, s, CH-pyrazole), 7.32--7.76 (15*H*, m, Ar-H), 9.89 (s, 1*H*, NHCO), 13.84 (1*H*, s, NH-pyrazole); ^13^C NMR: (300 MHz, DMSO-*d*~6~, δ (ppm)): 105.10 (CH, C4-pyrazole), 127.66 (CH, C-Ar), 128.66 (CH, C-Ar), 128.96 (CH, C-Ar), 130.21 (CH, C-Ar), 130.31 (CH, C-Ar), 130.46 (CH, C-Ar), 132.02 (C, C-Ar), 137.28 (C, C-Ar), 141.08 (C, C3-pyrazole), 145.70 (CH, N=CH), 153.35 (C, C5-pyrazole), 157.62 (C, C=O). ESI-MS: *m*/*z* = 366.9 \[M+H\]^+^, 389.0 \[M+H\]^+^.

3.3. X-Ray Crystallographic Analysis {#sec3dot3-ijms-18-02215}
------------------------------------

The compounds of **L1** and **L2** were obtained as single crystals by slow evaporation from ethanol solution of the pure compound at room temperature. Cell refinement and data reduction were carried out by Bruker SAINT. SHELXT was used to solve structure \[[@B36-ijms-18-02215],[@B37-ijms-18-02215]\]. The final refinement was carried out by full-matrix least-squares techniques with anisotropic thermal data for no hydrogen atoms on 𝐹. CCDC 1522882 and 1523265 for **L1** and **L2**, respectively, contain the supplementary crystallographic data for these compounds can be obtained free of charge from the Cambridge Crystallographic Data Centre via <http://www.ccdc.cam.ac.uk/data_request/cif>.

3.4. DFT Computational Method {#sec3dot4-ijms-18-02215}
-----------------------------

The computational studies of compounds **L1** and **L2** were performed at the B3LYP/6-31G level of theory using Gaussian 09 package programs \[[@B38-ijms-18-02215],[@B39-ijms-18-02215]\]. The optimization geometries of **L1** and **L2** were performed using the Berny analytical gradient optimization method \[[@B40-ijms-18-02215]\].

3.5. Catecholase Activity Measurement {#sec3dot5-ijms-18-02215}
-------------------------------------

Kinetic measurements were made spectrophotometrically on UV-vis spectrometer, following the appearance of *o*-quinone over time at 25 °C (390 nm absorbance maximum *ε* = 1600 L mol^−1^ cm^−1^ in methanol \[[@B35-ijms-18-02215]\]. The complexes were prepared in situ by successively mixing 0.15 mL of a solution (2 × 10^−3^ M) of CuX~2~·nH~2~O (X = Cl^−^, NO~3~^−^, CH~3~COO^−^ or SO~4~^2−^), with 0.15 mL of a solution (2 × 10^−3^ M) of ligand, then adding 2 mL of a solution of catechol at a concentration of 10^−1^ M.

4. Conclusions {#sec4-ijms-18-02215}
==============

In this work, we report the synthesis of six new hydrazone--pyrazole biomolecules (**L1**--**L6**) in excellent yields. The X-ray structures of **L1** and **L2** have been investigated herein for the first time. The theoretical calculations through DFT of **L1** and **L2** well supported the experimental findings. These ligands (**L1**--**L6**) and different Cu(II) salts demonstrate an efficient activity to catalyze the aerobic oxidation of the catechol into *o*-quinone compared to others recent catalysts described in the literatures. Interestingly, ligand **L6** exhibits an extremely high rate of oxidation, attaining 72.92 μmol·L^−1^·min^−1^, which is, to our knowledge, the best catalytic activity among the reported catalysts. Cu(II)-ligand complexes were generated in situ and the results obtained show that the oxidation depend highly on several parameters: the nature and concentration of the ligand, the nature of salts and the solvent effects. The results suggest that these new materials have potential for the oidation of the catechol into *o*-quinone, thus opening important perspectives.
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![The synthetic routes of compounds **L1**--**L6**: (**a**) hydrazine hydrate (80%), ethanol, reflux 5h; and (**b**) ethanol, acetic acid, reflux, 2--5 h.](ijms-18-02215-sch001){#ijms-18-02215-sch001}
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![Optimized geometry of **L1** and **L2**.](ijms-18-02215-g003){#ijms-18-02215-f003}
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![Catechol oxidation in the presence of copper complexes formed with **L6**.](ijms-18-02215-g006){#ijms-18-02215-f006}

![Catechol oxidation in methanol, in presence of formed **L6** copper complexes with different concentrations.](ijms-18-02215-g007){#ijms-18-02215-f007}

![Catechol oxidation in different solvents and in the presence of formed **L6** copper complexes (1 Equivalent of **L~6~** for 1 Equivalent of Cu(CH~3~COOH)~2~).](ijms-18-02215-g008){#ijms-18-02215-f008}
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###### 

Selected structural parameters by X-ray and theoretical calculations of compound **L~1~**.

  Bond Length (Å)   Experimental Bond Lengths   Calculated Bond Lengths   Bond Angle (°)   Experimental Bond Angles   Calculated Bond Angles
  ----------------- --------------------------- ------------------------- ---------------- -------------------------- ------------------------
  O1--C10           1.22(3)                     1.24                      N2--C9--C8       106.0(2)                   109.2
  O2--C14           1.36(3)                     1.39                      O1--C10--N3      122.8(2)                   125.0
  O2--C18           1.41(4)                     1.45                      N3--C10--C9      116.0(2)                   112.7
  O3--C15           1.36(3)                     1.38                      O1--C10--C9      121.3(2)                   122.2
  N1--N2            1.33(3)                     1.37                      N4--C11--C12     122.9(2)                   121.3
  N1--C7            1.33(3)                     1.38                      O2--C14--C13     125.7(2)                   126.0
  N2--C9            1.34(3)                     1.36                      C14--O2--C18     118.3(2)                   118.5
  N3--N4            1.38(3)                     1.37                      N2--N1--C7       105.3(2)                   113.2
  N3--C10           1.34(3)                     1.38                      N1--N2--C9       112.6(2)                   105.0
  N4--C11           1.27(3)                     1.29                      N4--N3--C10      119.5(2)                   121.0

ijms-18-02215-t002_Table 2

###### 

Selected structural parameters by X-ray and theoretical calculations of compound **L2**.

  Bond Length (Å)   Experimental Bond Lengths   Calculated Bond Lengths   Bond Angle (°)   Experimental Bond Angles   Calculated Bond Angles
  ----------------- --------------------------- ------------------------- ---------------- -------------------------- ------------------------
  O1--C10           1.22(2)                     1.21                      N2--N1--C7       113.4(15)                  113.6
  N1--N2            1.34(2)                     1.34                      N1--N2--C9       103.9(15)                  105.4
  N1--C7            1.34(3)                     1.37                      N4--N3--C10      119.2(17)                  117.2
  N2--C9            1.33(2)                     1.34                      N3--N4--C11      115.6(18)                  114.2
  N3--N4            1.38(2)                     1.41                      N1--C7--C6       122.7(17)                  122.39
  N3--C10           1.33(3)                     1.36                      N1--C7--C8       105.3(18)                  103.59
  N4--C11           1.26(3)                     1.27                      N2--C9--C8       111.4(16)                  109.21
  C15--C18          1.512(4)                    1.50                      N2--C9--C10      119.4(17)                  119.83
  N1--H             0.86(2)                     1.00                      N3--C10--C9      114.9(16)                  111.05
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###### 

Calculated energies of **L1** and **L2**.

  Molecular Energy (a.u.) (eV)    L1         L2
  ------------------------------- ---------- ----------
  *TE*                            −31008.6   −26911.4
  E~HOMO~                         −5.8186    −6.4850
  E~LUMO~                         −1.0152    −0.7349
  Gap *ΔE*                        4.8034     5.7500
  Chemical potential *µ* (D)      5.8871     6.3122
  Ionization potential (IP)       5.8186     6.4850
  Electron affinity (EA)          1.0152     0.7349
  Electron negatiity (*χ*)        3.4169     3.6100
  Global hardness (*η*)           2.4017     2.875
  Global electrophilicity (*ω*)   2.4306     2.2664
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###### 

Oxidation rate of catechol oxidation in methanol (µmol·L^−1^·min^−1^).

  Ligand/Metallic Salt   Cu(NO~3~)~2~   CuCl~2~   Cu(CH~3~COO)~2~   CuSO~4~
  ---------------------- -------------- --------- ----------------- ---------
  **L1**                 10.57          10.28     9.80              9.27
  **L2**                 15.52          0.05      22.92             16.06
  **L3**                 37.89          9.19      24.58             21.01
  **L4**                 17.71          11.43     15.02             6.57
  **L5**                 3.10           8.07      19.62             10.61
  **L6**                 27.77          40.27     60.50             72.92

ijms-18-02215-t005_Table 5

###### 

Comparison of the catalytic activity of various catalysts toward oxidation of the catechol into *o*-quinone, established in the same conditions, as given in previous literature.

  Cu(II)-Ligands                                              Cu(II) Salt Used   Oxidation Rate (µmol·L^−1^·min^−1^)   Ref.
  ----------------------------------------------------------- ------------------ ------------------------------------- --------------------------
  ligand **L6**                                               CuSO~4~            **72.920**                            \-
  ligand **L6**                                               Cu(CH~3~COO)~2~    **60.500**                            \-
  ligand **L6**                                               CuCl~2~            **40.270**                            \-
  *C*,*N*-bipyrazole                                          Cu(CH~3~COO)~2~    4.440                                 \[[@B29-ijms-18-02215]\]
  bipyrazolic tripode-prop-2-ylacetate                        Cu(CH~3~COO)~2~    11.825                                \[[@B30-ijms-18-02215]\]
  bipyrazolic tripode-4-hydroxyphenyl                         CuCl~2~            1.458                                 \[[@B31-ijms-18-02215]\]
  bipyrazolic tripode-3-hydroxypropyl                         CuSO~4~            28.990                                \[[@B32-ijms-18-02215]\]
  bipyrazolic tripode-3-hydroxypropyl                         CuCl~2~            4.378                                 \[[@B33-ijms-18-02215]\]
  indole-3-chalcone                                           Cu(CH~3~COO)~2~    31.780                                \[[@B34-ijms-18-02215]\]
  \[(3,5-dimethyl-pyrazol-1-ylmethyl)-amino\]-propionitrile   CuSO~4~            8.710                                 \[[@B35-ijms-18-02215]\]
